BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16378904)

  • 1. Novel radiation-enhancing agents in malignant gliomas.
    Zhang M; Chakravarti A
    Semin Radiat Oncol; 2006 Jan; 16(1):29-37. PubMed ID: 16378904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD; Taillandier L; Bernier V; Carnin C
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
    Colman H; Berkey BA; Maor MH; Groves MD; Schultz CJ; Vermeulen S; Nelson DF; Mehta MP; Yung WK;
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):818-24. PubMed ID: 16887285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemical modifiers in radiotherapy].
    Nagashima T; Takakura K
    Gan No Rinsho; 1989 Sep; 35(11):1369-71. PubMed ID: 2681875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy in the treatment of malignant gliomas.
    Stern JI; Raizer JJ
    Expert Rev Anticancer Ther; 2006 May; 6(5):755-67. PubMed ID: 16759165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of malignant glioma: steady progress with multimodal approaches.
    Ashby LS; Ryken TC
    Neurosurg Focus; 2006 Apr; 20(4):E3. PubMed ID: 16709034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New chemotherapy options for the treatment of malignant gliomas.
    Soffietti R; Rudà R; Trevisan E
    Anticancer Drugs; 2007 Jul; 18(6):621-32. PubMed ID: 17762390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary approaches to the treatment of malignant gliomas with radiation therapy.
    Leibel SA; Scott CB; Loeffler JS
    Semin Oncol; 1994 Apr; 21(2):198-219. PubMed ID: 8153665
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoradiotherapy in malignant glioma: standard of care and future directions.
    Stupp R; Hegi ME; Gilbert MR; Chakravarti A
    J Clin Oncol; 2007 Sep; 25(26):4127-36. PubMed ID: 17827463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gliomas in adults: primary non-surgical treatment].
    Poulsen HS
    Ugeskr Laeger; 2006 Nov; 168(47):4082-5. PubMed ID: 17134603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
    Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
    Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined radio- and chemotherapy of brain tumours in adult patients.
    Nieder C; Mehta MP; Jalali R
    Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):515-24. PubMed ID: 19487112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glioblastoma treatment in 2010].
    Djedid R; Tomasi O; Haidara A; Rynkowski M; Lefranc F
    Rev Med Brux; 2009; 30(5):496-505. PubMed ID: 19998795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.